Moderna, Inc. - Common Stock (NQ:MRNA)

Topics Stocks

Abbas Hussain Joins Moderna's Board of Directors

October 02, 2024

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.

The Covid Era Tech Promises To Reinvent Cancer Treatment ↗

October 01, 2024

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 30, 2024

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today ↗

September 24, 2024

Via Benzinga

September 30, 2024

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 30, 2024

From Bernstein Liebhard LLP

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

September 30, 2024

These stocks might look like bad picks. But appearances can be deceiving.

3 Surprisingly Underrated Stocks to Buy Right Now ↗

September 28, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 25, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

September 24, 2024

From The Rosen Law Firm PA

These innovative companies have the tools to rebound.

Top 3 Health Care Stocks That May Explode This Month ↗

September 23, 2024

Via Benzinga

2 Beaten-Down Stocks to Buy and Hold for a Decade ↗

September 23, 2024

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 23, 2024

From Bernstein Liebhard LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 21, 2024

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...

Pfizer Advances On Its Cancer Journey ↗

September 20, 2024

Via Benzinga

Down 13% in 1 Day, Is Moderna Stock in Trouble? ↗

September 20, 2024

There's no hope of it recovering to its prior heights anytime soon.

if you're looking for a way to escape the market volatility, here are three stocks that are trading near their 52-week lows with solid catalysts for growth

3 Beaten-Down Stocks Ready for a Comeback

September 19, 2024

Via MarketBeat

Topics Economy

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗

September 19, 2024

This strategic play will take time to pay off, but it could keep growth going.

Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

September 18, 2024

From Robbins LLP

Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse ↗

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 18, 2024

Via Benzinga

September 18, 2024

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and...

Via Benzinga

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗

September 18, 2024

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 17, 2024

S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers ↗

September 17, 2024

S&P 500 hits new record highs amidst expectations for Fed interest rate decision. Small-cap stocks outperform, while uncertainty remains.

Via Benzinga

Topics Economy Stocks

Momentum Investing Gives You An Edge, Until It Doesn’t ↗

September 17, 2024

Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.

Via Talk Markets

Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday? ↗

September 17, 2024

Wall Street experienced a slightly positive session Tuesday, supported by investor optimism as the Federal Open Market Committee (FOMC) kicked off its two-day meeting, expected to deliver the first...

Via Benzinga

Topics Economy

What's Going On With Moderna Shares Tuesday? ↗

September 17, 2024

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine.

Via Benzinga

Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older

September 17, 2024